A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Name: A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Published: 2012
License: Public Domain

Teva Branded Pharmaceutical Products R&D, Inc. · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

asthma

asthma, dry powder inhaler, short-acting beta2-agonist, saba, bronchoconstriction, bronchodilation, bronchodilator, metered dose inhaler, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Related documents